Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07693231 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or Overweight

Name: A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or Overweight — clinical trial record (NCT07693231)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 1

SponsorBoehringer Ingelheim

Started2026-07-21

View on ClinicalTrials.gov ↗

Amendment history

2026-09-24

Enrollment closed, study ongoing

2026-07-23

Study Status, Contacts/Locations v2

Recruitment opened

Study sitesdetails revised at 3 of 3 sites

2026-07-16

Study Status v1

Completion date2027-01-29→2027-01-05

Start date2026-07-30→2026-07-21

2026-07-03

Original filing

Boehringer Ingelheim

221 trials monitored

See 15 trials at risk

Obesity

3,523 trials monitored

See 133 trials at risk

Part 1: To investigate safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BI 3034701 in Japanese male and female participants with body mass index (BMI) ≥27.0 kg/m² or more following subcutaneous administration of multiple rising doses over 16 weeks. Part 2: To investigate safety, tolerability, and PK of BI 3034701 in Japanese male and female healthy participants with BMI ≥23.0 to \<27.0 kg/m² following subcutaneous administration of multiple rising doses over 7 weeks.

Trial Details

NCT Number	NCT07693231
Lead Sponsor	Boehringer Ingelheim
Conditions	Healthy, Obesity
Enrollment	48 participants
Start Date	2026-07-21
Primary Completion	2026-12-22 (estimated)
Study Completion	2027-01-05 (estimated)
Updated on ClinicalTrials.gov	2026-10-01